From GlobeNewswire: 2025-01-23 03:30:00

Nxera Pharma Co. Ltd will announce earnings for 2024 on February 14, 2025, with a live webinar featuring key executives. The company focuses on developing specialty medicines, with over 30 active programs addressing major medical needs globally. Nxera employs over 350 people in key locations and is listed on the Tokyo Stock Exchange.

The webinar will be open to existing and potential investors, analysts, and will include a Q&A session. Presentation slides will be available on the company’s website. Nxera Pharma is a technology-powered biopharma company with a focus on improving the lives of patients with unmet medical needs globally. The company leverages its unique drug discovery platform to develop innovative solutions.

Nxera Pharma is listed on the Tokyo Stock Exchange and has key locations in Tokyo, Osaka, London, Cambridge, Basel, and Seoul. The company is actively involved in developing new medicines to address various medical needs. Nxera’s pipeline includes programs in neurology, GI, immunology, metabolic disorders, and rare diseases.

Investors and analysts can pre-register for the webinar on the company’s website. Nxera Pharma is committed to developing and commercializing innovative products to address unmet medical needs. The company’s focus is on leveraging its unique drug discovery platform to develop best-in-class candidates.

Media and Investor Relations for Nxera Pharma can be contacted for further information. The company is actively involved in developing and commercializing products to address major medical needs. Nxera Pharma focuses on leveraging its unique drug discovery platform to create innovative solutions.



Read more at GlobeNewswire:: Nxera Pharma Webinar Presentation for FY2024 Financial